These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30182424)

  • 1. Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation.
    Nakatsuka T; Soroida Y; Nakagawa H; Shindo T; Sato M; Soma K; Nakagomi R; Kobayashi T; Endo M; Hikita H; Sato M; Gotoh H; Iwai T; Yasui M; Shinozaki-Ushiku A; Shiraga K; Asakai H; Hirata Y; Fukayama M; Ikeda H; Yatomi Y; Tateishi R; Inuzuka R; Koike K
    Hepatol Res; 2019 Mar; 49(3):304-313. PubMed ID: 30182424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive ultrasound technique for assessment of liver fibrosis and cardiac function in Fontan-associated liver disease: diagnosis based on elastography and hepatic vein waveform type.
    Koizumi Y; Hirooka M; Tanaka T; Watanabe T; Yoshida O; Tokumoto Y; Higaki T; Eguchi M; Abe M; Hiasa Y
    J Med Ultrason (2001); 2021 Apr; 48(2):235-244. PubMed ID: 33417157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of intrahepatic blood flow by Doppler ultrasonography: relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension.
    Zhang L; Yin J; Duan Y; Yang Y; Yuan L; Cao T
    BMC Gastroenterol; 2011 Jul; 11():84. PubMed ID: 21767412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive biomarkers of Fontan-associated liver disease.
    Emamaullee J; Khan S; Weaver C; Goldbeck C; Yanni G; Kohli R; Genyk Y; Zhou S; Shillingford N; Sullivan PM; Takao C; Detterich J; Kantor PF; Cleveland JD; Herrington C; Ram Kumar S; Starnes V; Badran S; Patel ND
    JHEP Rep; 2021 Dec; 3(6):100362. PubMed ID: 34693238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Non-invasive Method for Predicting Liver Fibrosis by Quantifying the Hepatic Vein Waveform.
    Soroida Y; Nakatsuka T; Sato M; Nakagawa H; Tanaka M; Yamauchi N; Wake T; Nakagomi R; Kinoshita MN; Minami T; Uchino K; Enooku K; Asaoka Y; Tanaka Y; Endo M; Nakamura A; Kobayashi T; Kurihara M; Hikita H; Sato M; Gotoh H; Iwai T; Fukayama M; Ikeda H; Tateishi R; Yatomi Y; Koike K
    Ultrasound Med Biol; 2019 Sep; 45(9):2363-2371. PubMed ID: 31303401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
    Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
    Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormality of the hepatic vein waveforms in cirrhotic patients with portal hypertension and its prognostic implications.
    Kawanaka H; Kinjo N; Anegawa G; Yoshida D; Migoh S; Konishi K; Ohta M; Yamaguchi S; Tomikawa M; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e129-36. PubMed ID: 17924952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of elastography versus biopsy in assessing severity of liver fibrosis in young Fontan patients.
    Bulut OP; Bailey SS; Bhat DP
    Cardiol Young; 2024 May; ():1-7. PubMed ID: 38804649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver.
    Oguzkurt L; Yildirim T; Torun D; Tercan F; Kizilkilic O; Niron EA
    Eur J Radiol; 2005 May; 54(2):253-7. PubMed ID: 15837406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of biomarkers of hepatic fibrosis in adult Fontan patients.
    Wu FM; Earing MG; Aboulhosn JA; Johncilla ME; Singh MN; Odze RD; Ukomadu C; Gauvreau K; Landzberg MJ; Valente AM;
    J Heart Lung Transplant; 2017 Feb; 36(2):211-219. PubMed ID: 27592026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Fontan Associated Liver Disease: Non-invasive Evaluation with Serologic Markers and Acoustic Radiation Force Impulse (ARFI) Elastography.
    Ofei SY; Texter K; Gariepy C; Smith S; Zaidi AN; Phelps C
    Prog Pediatr Cardiol; 2019 Jun; 53():21-27. PubMed ID: 32818014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings.
    Evans WN; Acherman RJ; Ciccolo ML; Carrillo SA; Galindo A; Rothman A; Mayman GA; Adams EA; Reardon LC; Winn BJ; Yumiaco NS; Shimuizu L; Inanaga Y; Deleon RJ; Restrepo H
    Congenit Heart Dis; 2018 Jan; 13(1):38-45. PubMed ID: 29194972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation.
    Poterucha JT; Johnson JN; Qureshi MY; O'Leary PW; Kamath PS; Lennon RJ; Bonnichsen CR; Young PM; Venkatesh SK; Ehman RL; Gupta S; Smyrk TC; Dearani JA; Warnes CA; Cetta F
    Mayo Clin Proc; 2015 Jul; 90(7):882-94. PubMed ID: 26059757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort.
    Munsterman ID; Duijnhouwer AL; Kendall TJ; Bronkhorst CM; Ronot M; van Wettere M; van Dijk APJ; Drenth JPH; Tjwa ETTL;
    Eur Heart J; 2019 Apr; 40(13):1057-1068. PubMed ID: 30346512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.
    Baik SK; Kim JW; Kim HS; Kwon SO; Kim YJ; Park JW; Kim SH; Chang SJ; Lee DK; Han KH; Um SH; Lee SS
    Radiology; 2006 Aug; 240(2):574-80. PubMed ID: 16864678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study.
    Goldberg DJ; Surrey LF; Glatz AC; Dodds K; O'Byrne ML; Lin HC; Fogel M; Rome JJ; Rand EB; Russo P; Rychik J
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography.
    Yoo BW; Choi JY; Eun LY; Park HK; Park YH; Kim SU
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1498-505. PubMed ID: 24823284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic vein waveforms in liver cirrhosis re-evaluated.
    K C S; Sharma D; Chataut SP
    Hepatol Int; 2010 Dec; 5(1):581-5. PubMed ID: 21442056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fontan-associated liver disease: Diagnosis, surveillance, and management.
    de Lange C; Möller T; Hebelka H
    Front Pediatr; 2023; 11():1100514. PubMed ID: 36937979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.